Clinico–Epidemio-Microbiological Exploratory Review Among COVID-19 Patients with Secondary Infection in Central India

References

• Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.105924
   PubMed Web of Science ®Google Scholar
• WHO Coronavirus (COVID-19) dashboard. Available from: https://covid19.who.int. Accessed November 27, 2021.
   Google Scholar
• India: WHO Coronavirus Disease (COVID-19) dashboard with vaccination data. Available from: https://covid19.who.int. Accessed November 27, 2021.
   Google Scholar
• Zhou P, Liu Z, Chen Y, Xiao Y, Huang X, Fan XG. Bacterial and fungal infections in COVID-19 patients: a matter of concern. Infect Control Hosp Epidemiol. 2020;41(9):1124–1125. doi:10.1017/ice.2020.156
   PubMed Web of Science ®Google Scholar
• Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198(7):962–970. doi:10.1086/591708
   PubMed Web of Science ®Google Scholar
• Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8:1041. doi:10.3389/fmicb.2017.01041
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629. doi:10.1016/j.cmi.2020.07.016
   PubMed Web of Science ®Google Scholar
• Ripa M, Galli L, Poli A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021;27(3):451–457. doi:10.1016/j.cmi.2020.10.021
   PubMed Web of Science ®Google Scholar
• Helle KB, Sadiku A, Zelleke GM, et al. Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity? PLoS One. 2021;16(7):e0253758. doi:10.1371/journal.pone.0253758
   Web of Science ®Google Scholar
• Melenotte C, Silvin A, Goubet AG, et al. Immune responses during COVID-19 infection. OncoImmunology. 2020;9(1):1807836. doi:10.1080/2162402X.2020.1807836
   PubMed Web of Science ®Google Scholar
• Torres T, Puig L. Managing cutaneous immune-mediated diseases during the COVID-19 pandemic. Am J Clin Dermatol. 2020;21(3):307–311. doi:10.1007/s40257-020-00514-2
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Sig Transduct Target Ther. 2020;5(1):33. doi:10.1038/s41392-020-0148-4
   PubMed Web of Science ®Google Scholar
• Zhao Q, Meng M, Kumar R, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis. Int J Infect Dis. 2020;96:131–135. doi:10.1016/j.ijid.2020.04.086
   PubMed Web of Science ®Google Scholar
• Yang L, Liu S, Liu J, et al. COVID-19: immunopathogenesis and immunotherapeutics. Sig Transduct Target Ther. 2020;5(1):128. doi:10.1038/s41392-020-00243-2
   PubMed Web of Science ®Google Scholar
• Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020;8(1):36. doi:10.1186/s40560-020-00453-4
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–88. doi:10.1016/j.cmi.2020.07.041
   PubMed Web of Science ®Google Scholar
• Vijay S, Bansal N, Rao BK, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist. 2021;14:1893–1903. doi:10.2147/IDR.S299774
   PubMed Web of Science ®Google Scholar
• Weinstein MP; Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 2019.
   Google Scholar
• Alexander BD, Procop GW, Dufresne P, editors; Clinical and Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Yeasts. CLSI; 2017.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Khurana S, Singh P, Sharad N, et al. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: implication on antimicrobial resistance. Indian J Med Microbiol. 2021;39(2):147–153. doi:10.1016/j.ijmmb.2020.10.014
   PubMed Web of Science ®Google Scholar
• Russell CD, Fairfield CJ, Drake TM, et al. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021;2(8):e354–e365. doi:10.1016/S2666-5247(21)00090-2
   PubMedGoogle Scholar
• Bardi T, Pintado V, Gomez-Rojo M, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis. 2021;40(3):495–502. doi:10.1007/s10096-020-04142-w
   PubMed Web of Science ®Google Scholar
• Gomez-Simmonds A, Annavajhala MK, McConville TH, et al. Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital. J Antimicrob Chemother. 2021;76(2):380–384. doi:10.1093/jac/dkaa466
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Yang Y, et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control. 2020;9(1):153. doi:10.1186/s13756-020-00819-1
   PubMed Web of Science ®Google Scholar
• He S, Liu W, Jiang M, et al. Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: a multi-center study. PLoS One. 2021;16(4):e0249668. doi:10.1371/journal.pone.0249668
   PubMed Web of Science ®Google Scholar
• Nasir N, Rehman F, Omair SF. Risk factors for bacterial infections in patients with moderate to severe COVID-19: a case-control study. J Mel Virol. 2021;93(7):4564–4569. doi:10.1002/jmv.27000
   PubMed Web of Science ®Google Scholar
• Søgaard KK, Baettig V, Osthoff M, et al. Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia. J Intensive Care. 2021;9(1):10. doi:10.1186/s40560-021-00526-y
   Web of Science ®Google Scholar
• Nassar Y, Mokhtar A, Elhadidy A, et al. Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study. J Infect Public Health. 2021;14(10):1381–1388. doi:10.1016/j.jiph.2021.06.012
   Web of Science ®Google Scholar
• Mehta M, Purpura LJ, McConville TH, et al. What about tocilizumab? A retrospective study from a NYC hospital during the COVID-19 outbreak. PLoS One. 2021;16(4):e0249349. doi:10.1371/journal.pone.0249349
   Web of Science ®Google Scholar
• Cai Q, Huang D, Ou P, et al. COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75(7):1742–1752. doi:10.1111/all.14309
   PubMed Web of Science ®Google Scholar
• Sharov KS. SARS-CoV-2-related pneumonia cases in pneumonia picture in Russia in March-May 2020: secondary bacterial pneumonia and viral co-infections. J Glob Health. 2020;10(2):020504. doi:10.7189/jogh.10.020504
   Web of Science ®Google Scholar